Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease

Brain Research

Volumn 1184, Issue 1, 2007, Pages 10-16

  Blackinton, Jeff G ^a,b   Anvret, Anna ^a   Beilina, Alexandra ^b   Olson, Lars ^a   Cookson, Mark R ^b   Galter, Dagmar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

In situ hybridization; Neurodegeneration; PARK6

Indexed keywords

MESSENGER RNA; PINK1 ENZYME; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; BRAIN; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MICE; NEURONS; PARKINSON DISEASE; PROTEIN KINASES; RATS; RNA, MESSENGER;

RATTUS; RODENTIA;

EID: 36448932411     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.09.056     Document Type: Article

References (25)

1. Albanese A., Valente E.M., Romito L.M., Bellacchio E., Elia A.E., and Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology 64 (2005) 1958-1960
2. Bader V., Ran Z., X., Lubbert H., and Stichel C.C. Expression of DJ-1 in the adult mouse CNS. Brain Res. 1041 (2005) 102-111
3. Beilina A., van der B.M., Ahmad R., Kesavapany S., Miller D.W., Petsko G.A., and Cookson M.R. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5703-5708
4. Cookson M.R. The biochemistry of Parkinson's disease. Ann. Rev. Biochem. 74 (2005) 29-52
5. D'Agata V., Grimaldi M., Pascale A., and Cavallaro S. Regional and cellular expression of the parkin gene in the rat cerebral cortex. Eur. J. Neurosci. 12 (2000) 3583-3588
6. Galter D., Carmine A., Buervenich S., Duester G., and Olson L. Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain. Eur. J. Biochem. 270 (2003) 1316-1326
7. Galter D., Westerlund M., Carmine A., Lindqvist E., Sydow O., and Olson L. LRRK2 expression linked to dopamine-innervated areas. Ann. Neurol. 59 (2006) 714-719
8. Gandhi S., Muqit M.M., Stanyer L., Healy D.G., Abou-Sleiman P.M., Hargreaves I., Heales S., Ganguly M., Parsons L., Lees A.J., Latchman D.S., Holton J.L., Wood N.W., and Revesz T. PINK1 protein in normal human brain and Parkinson's disease. Brain 129 (2006) 1720-1731
9. Hoepken H.H., Gispert S., Morales B., Wingerter O., Del Turco D., Mulsch A., Nussbaum R.L., Muller K., Drose S., Brandt U., Deller T., Wirth B., Kudin A.P., Kunz W.S., and Auburger G. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol. Dis. 25 (2007) 401-411
10. Horowitz J.M., Myers J., Stachowiak M.K., and Torres G. Identification and distribution of Parkin in rat brain. Neuroreport 10 (1999) 3393-3397
11. Khan N.L., Valente E.M., Bentivoglio A.R., Wood N.W., Albanese A., Brooks D.J., and Piccini P. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann. Neurol. 52 (2002) 849-853
12. Miller D.W., Johnson J.M., Solano S.M., Hollingsworth Z.R., Standaert D.G., and Young A.B. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J. Neural Transm. 112 (2005) 1613-1624
13. Muqit M.M., Abou-Sleiman P.M., Saurin A.T., Harvey K., Gandhi S., Deas E., Eaton S., Payne S., Venner K., Matilla A., Healy D.G., Gilks W.P., Lees A.J., Holton J., Revesz T., Parker P.J., Harvey R.J., Wood N.W., and Latchman D.S. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J. Neurochem. 98 (2006) 156-169
14. Murakami T., Moriwaki Y., Kawarabayashi T., Nagai M., Ohta Y., Deguchi K., Kurata T., Morimoto N., Takehisa Y., Matsubara E., Ikeda M., Harigaya Y., Shoji M., Takahashi R., and Abe K. PINK1, a gene product of PARK6, accumulates in alpha-synucleinopathy brains. J. Neurol. Neurosurg. Psychiatry 78 (2007) 653-654
15. Nakajima A., Kataoka K., Hong M., Sakaguchi M., and Huh N.H. BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. Cancer Lett. 201 (2003) 195-201
16. Petit A., Kawarai T., Paitel E., Sanjo N., Maj M., Scheid M., Chen F., Gu Y., Hasegawa H., Salehi-Rad S., Wang L., Rogaeva E., Fraser P., Robinson B., George-Hyslop P., and Tandon A. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280 (2005) 34025-34032
17. Shang H., Lang D., Jean-Marc B., and Kaelin-Lang A. Localization of DJ-1 mRNA in the mouse brain. Neurosci. Lett. 367 (2004) 273-277
18. Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T., Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N., and Mizuno Y. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45 (1999) 668-672
19. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E.M., and Casari G. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14 (2005) 3477-3492
20. Solano S.M., Miller D.W., Augood S.J., Young A.B., and Penney Jr. J.B. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann. Neurol. 47 (2000) 201-210
21. Stichel C.C., Augustin M., Kuhn K., Zhu X.R., Engels P., Ullmer C., and Lubbert H. Parkin expression in the adult mouse brain. Eur. J. Neurosci. 12 (2000) 4181-4194
22. Taymans J.M., Van den H.C., and Baekelandt V. Distribution of PINK1 and LRRK2 in rat and mouse brain. J. Neurochem. 98 (2006) 951-961
23. Unoki M., and Nakamura Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20 (2001) 4457-4465
24. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., and Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
25. Zhu J.H., Guo F., Shelburne J., Watkins S., and Chu C.T. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol. 13 (2003) 473-481